Comparison of Isolated Lymphocyte and Whole Blood-Based CBMN Assays for Radiation Triage
Cytogenetic and Genome Research · 2023
DOI: 10.1159/000533488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytogenetic and Genome Research, 2023. Verfasst von Antonella Bertucci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Radiological Research, Columbia University, New York, New York, USA. Hauptthemen laut MEDLINE: Radiometry, Cytokinesis. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Following a mass-casualty nuclear/radiological event, there will be an important need for rapid and accurate estimation of absorbed dose for biological triage. The cytokinesis-block micronucleus (CBMN) assay is an established and validated cytogenetic biomarker used to assess DNA damage in irradiated peripheral blood lymphocytes. Here, we describe an intercomparison experiment between two biodosimetry laboratories, located at Columbia University (CU) and Health Canada (HC) that performed different variants of the human blood CBMN assay to reconstruct dose in human blood, with CU performing the assay on isolated lymphocytes and using semi-automated scoring whereas HC used the more conventional whole blood assay. Although the micronucleus yields varied significantly between the two assays, the predicted doses closely matched up to 4 Gy – the range from which the HC calibration curve was previously established. These results highlight the importance of a robust calibration curve(s) across a wide age range of donors that match the exposure scenario as closely as possible and that will account for differences in methodology between laboratories. We have seen that at low doses, variability in the results may be attributed to variation in the processing while at higher doses the variation is dominated by inter-individual variation in cell proliferation. This interlaboratory collaboration further highlights the usefulness of the CBMN endpoint to accurately reconstruct absorbed dose in human blood after ionizing radiation exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Radiological Research, Columbia University, New York, New York, USA.
- Currently at: Loma Linda University Medical Center, Loma Linda, California, USA.
- Consumer and Clinical Radiation Protection Bureau, Health Canada, Ottawa, Ontario, Canada.
Förderung
- NIAID NIH HHS
Zitieren
APA
Bertucci, A., Wilkins, R. C., Lachapelle, S., Turner, H. C., Brenner, D. J., & Garty, G. (2023). Comparison of Isolated Lymphocyte and Whole Blood-Based CBMN Assays for Radiation Triage. Cytogenetic and Genome Research. https://doi.org/10.1159/000533488
Vancouver
Bertucci A, Wilkins RC, Lachapelle S, Turner HC, Brenner DJ, Garty G. Comparison of Isolated Lymphocyte and Whole Blood-Based CBMN Assays for Radiation Triage. Cytogenetic and Genome Research. 2023. doi:10.1159/000533488
BibTeX
@article{Bertucci2023,
author = {Bertucci, Antonella and Wilkins, Ruth C and Lachapelle, Sylvie and Turner, Helen C and Brenner, David J and Garty, Guy},
title = {Comparison of Isolated Lymphocyte and Whole Blood-Based CBMN Assays for Radiation Triage},
journal = {Cytogenetic and Genome Research},
year = {2023},
doi = {10.1159/000533488}
}
EUVIMED